Literature DB >> 22595940

Diagnostic approaches to apparent homozygosity.

Megan L Landsverk1, Ganka V Douglas, Sha Tang, Victor W Zhang, Guo-Li Wang, Jing Wang, Lee-Jun C Wong.   

Abstract

PURPOSE: Sanger sequencing is a mainstay for the identification of gene mutations used in molecular diagnostic laboratories. However, in autosomal recessive disorders, failure of allele amplification can occur for a variety of reasons, leading heterozygous mutations to appear homozygous. We sought to investigate the frequency at which apparently homozygous mutations detected by Sanger sequencing in our laboratory appeared homozygous due to other molecular etiologies.
METHODS: A review of 12,406 cases from 40 different genetic tests that were submitted to the Medical Genetics Laboratories at Baylor College of Medicine for Sanger sequence analysis was performed. The molecular status of apparently homozygous cases was further investigated by testing parents using various methods.
RESULTS: A total of 291 cases of apparent homozygosity were identified, ranging from 0 to 37% of the total per gene. One-third of the apparently homozygous cases were followed up by parental testing. Parental carrier status was confirmed in 88% of the cases. Of the cases in which parental carrier status could not be confirmed, deletions encompassing point mutations, allele dropout due to single-nucleotide polymorphisms at primer sites, and uniparental isodisomy were observed.
CONCLUSION: For individuals with autosomal recessive disorders and apparently homozygous mutations, confirmation by parental testing can rule out other causes of apparent homozygosity, including allele dropout, copy number variations, and uniparental isodisomy.

Entities:  

Mesh:

Year:  2012        PMID: 22595940     DOI: 10.1038/gim.2012.58

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  13 in total

Review 1.  Challenges of bringing next generation sequencing technologies to clinical molecular diagnostic laboratories.

Authors:  Lee-Jun C Wong
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

2.  Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutations.

Authors:  A Morrone; K L Tylee; M Al-Sayed; A C Brusius-Facchin; A Caciotti; H J Church; M J Coll; K Davidson; M J Fietz; L Gort; M Hegde; F Kubaski; L Lacerda; F Laranjeira; S Leistner-Segal; S Mooney; S Pajares; L Pollard; I Ribeiro; R Y Wang; N Miller
Journal:  Mol Genet Metab       Date:  2014-03-20       Impact factor: 4.797

Review 3.  DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.

Authors:  Dimitre R Simeonov; Xinjing Wang; Chen Wang; Yuri Sergeev; Monika Dolinska; Matthew Bower; Roxanne Fischer; David Winer; Genia Dubrovsky; Joan Z Balog; Marjan Huizing; Rachel Hart; Wadih M Zein; William A Gahl; Brian P Brooks; David R Adams
Journal:  Hum Mutat       Date:  2013-04-30       Impact factor: 4.878

4.  Uniparental isodisomy as a cause of recessive Mendelian disease: a diagnostic pitfall with a quick and easy solution in medium/large NGS analyses.

Authors:  Florian Erger; Karin Burau; Michael Elsässer; Katharina Zimmermann; Ute Moog; Christian Netzer
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

5.  An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease.

Authors:  Tobias Eisenberger; Christian Decker; Milan Hiersche; Ruben C Hamann; Eva Decker; Steffen Neuber; Valeska Frank; Hanno J Bolz; Henry Fehrenbach; Lars Pape; Burkhard Toenshoff; Christoph Mache; Kay Latta; Carsten Bergmann
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

Review 6.  Morquio A syndrome-associated mutations: a review of alterations in the GALNS gene and a new locus-specific database.

Authors:  Amelia Morrone; Anna Caciotti; Robert Atwood; Kathryn Davidson; Chaoyi Du; Patricia Francis-Lyon; Paul Harmatz; Matthew Mealiffe; Sean Mooney; Tal Ronnen Oron; April Ryles; Karl A Zawadzki; Nicole Miller
Journal:  Hum Mutat       Date:  2014-09-17       Impact factor: 4.878

7.  The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay.

Authors:  Hansook Kim Chong; Tao Wang; Hsiao-Mei Lu; Sara Seidler; Hong Lu; Steven Keiles; Elizabeth C Chao; A J Stuenkel; Xiang Li; Aaron M Elliott
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

8.  Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).

Authors:  Vadieh Ghodsinejad Kalahroudi; Behnam Kamalidehghan; Ahoura Arasteh Kani; Omid Aryani; Mahdi Tondar; Fatemeh Ahmadipour; Lip Yong Chung; Massoud Houshmand
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

9.  Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing.

Authors:  Yanming Feng; David Chen; Guo-Li Wang; Victor Wei Zhang; Lee-Jun C Wong
Journal:  Genet Med       Date:  2014-07-17       Impact factor: 8.822

10.  Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management.

Authors:  Susanna Zucca; Margherita Villaraggia; Stella Gagliardi; Gaetano Salvatore Grieco; Marialuisa Valente; Cristina Cereda; Paolo Magni
Journal:  BMC Bioinformatics       Date:  2016-11-08       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.